Published by MBA Skool Team, Last Updated: April 12, 2020
SWOT analysis of Ranbaxy analyses the brand by its strengths, weaknesses, opportunities & threats. In Ranbaxy SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.
SWOT Analysis is a proven management framework which enables a brand like Ranbaxy to benchmark its business & performance as compared to the competitors. Ranbaxy is one of the leading brands in the pharma and healthcare sector.
The article below lists the Ranbaxy SWOT (Strengths, Weaknesses, Opportunities, Threats), top Ranbaxy competitors and includes its target market, segmentation, positioning & Unique Selling Proposition (USP).
Healthcare professionals, wholesalers, generic distributors, and hospitals
A diversifies global healthcare company focused on patient’s needs
SWOT Analysis of Ranbaxy
For Ranbaxy, SWOT analysis can help the brand focus on building upon its strengths and opportunities while addressing its weaknesses as well as threats to improve its market position. Let us start the Ranbaxy SWOT Analysis:
The strengths of Ranbaxy looks at the key aspects of its business which gives it competitive advantage in the market. Some important factors in a brand's strengths include its financial position, experienced workforce, product uniqueness & intangible assets like brand value. Below are the Strengths in the SWOT Analysis of Ranbaxy :
1.Top 10 Global Generic Company with a spread over 125 countries
2. over 13,000 well trained Employees, over 50 nationalities
3. Strong presence in the International market with a major share and a strong presence in India as well
4.It has operations in nearly 50 countries and has 7 manufacturing plants
The weaknesses of a brand are certain aspects of its business which are it can improve to increase its position further. Certain weaknesses can be defined as attributes which the company is lacking or in which the competitors are better. Here are the weaknesses in the Ranbaxy SWOT Analysis:
1. It is heavily dependent upon generics for its revenue generation
2. Constantly regulated policies by the govt means operational efficiency is affected
The opportunities for any brand can include areas of improvement to increase its business. A brand's opportunities can lie in geographic expansion, product improvements, better communication etc. Following are the opportunities in Ranbaxy SWOT Analysis:
1.increasing health awareness
2.Improvement in distribution network & brand building
3. They can leverage Synriam, anti-malarial drug in brand building
The threats for any business can be factors which can negatively impact its business. Some factors like increased competitor activity, changing government policies, alternate products or services etc. can be threats. The threats in the SWOT Analysis of Ranbaxy are as mentioned:
1.Increasingly stringent FDA Regulations
2.Exchange rate fluctuations
3.Global economic slowdown
There are several brands in the market which are competing for the same set of customers. Below are the top 4 competitors of Ranbaxy:
This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.
Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to Ranbaxy. This section covers SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP of more than 2500 brands from over 20 industry sectors.
The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way. Edit the brand or add a new one to SWOT Analysis section : Contribute